Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Nūhou

Nā Hopena Hou o ka CD7-Targeted CAR-T Therapy no T-ALL a me T-LBL

Nā Hopena Hou o ka CD7-Targeted CAR-T Therapy no T-ALL a me T-LBL

2024-06-18

Ua hōʻike ʻia kahi noiʻi hou i nā hopena hoʻohiki o ka CD7-targeted chimeric antigen receptor (CAR) T cell therapy i ka mālama ʻana i nā maʻi me ka relapsed a refractory T-cell acute lymphoblastic leukemia (T-ALL) a me T-cell lymphoblastic lymphoma (T-LBL).

nānā i nā kikoʻī
Ka Uhi ʻana o ka Hālāwai Makahiki a me ka Hōʻikeʻike ASH 2024

Ka Uhi ʻana o ka Hālāwai Makahiki a me ka Hōʻikeʻike ASH 2024

2024-06-13

E mālama ʻia ana ka Hālāwai Makahiki 66 o ka ʻAhahui ʻAmelika o Hematology (ASH) mai ka lā 7-10 o Dekemaba, 2024, ma ke Kikowaena ʻAha Kūkākūkā o San Diego, e hōʻike ana i ka noiʻi hou a me nā holomua i ka hematology.

nānā i nā kikoʻī
Ke hoʻolaha nei i ka 2024 Annual Lu Daopei Hematology Forum i ʻAukake

Ke hoʻolaha nei i ka 2024 Annual Lu Daopei Hematology Forum i ʻAukake

2024-06-11

E mālama ʻia ana ka 12th Annual Lu Daopei Hematology Forum ma ʻAukake 23-24, 2024, ma ke Kikowaena ʻAha Kūkākūkā o Beijing International. E hui pū me mākou no nā kūkākūkā ʻike a me nā holomua hou loa i ka hematology.

nānā i nā kikoʻī
Manaʻolana Hou i ka Lapaʻau ʻana i ka Maʻi Kanesa: Puka Mai ka Lapaʻau TILs ma ke ʻano he Palena Aʻe

Manaʻolana Hou i ka Lapaʻau ʻana i ka Maʻi Kanesa: Puka Mai ka Lapaʻau TILs ma ke ʻano he Palena Aʻe

2024-06-05

ʻOiai nā pilikia e hoʻomau nei i ka ʻoihana a me ke kālepa ʻana, ke hoʻoponopono ʻia nei nā palena o ka lāʻau CAR-T e kahi ala hou e hoʻohiki nei: ka lāʻau Tumor-Infiltrating Lymphocyte (TIL). Ke hōʻike nei kēia holomua i kahi au hou i ke kaua ʻana i nā puʻupuʻu paʻa.

nānā i nā kikoʻī

ʻO nā Cellular Therapies ka wā e hiki mai ana o ka maʻi Autoimmune?

2024-04-30

Hiki paha i kahi lāʻau lapaʻau kipi no nā maʻi ʻaʻai ke mālama a hoʻonohonoho hou i ka ʻōnaehana pale e hāʻawi i ke kala ʻana no ka manawa lōʻihi a i ʻole e hoʻōla paha i kekahi mau maʻi autoimmune.

nānā i nā kikoʻī
Ka Wehe ʻana o ASH 2023 | Hōʻike ʻo Kauka Peihua Lu iā CAR-T no ka Noiʻi AML Relapsed / Refractory

Ka Wehe ʻana o ASH 2023 | Hōʻike ʻo Kauka Peihua Lu iā CAR-T no ka Noiʻi AML Relapsed / Refractory

2024-04-09
Ua mālama ʻia kahi haʻawina lapaʻau pae I o CD7 CAR-T no R/R AML e ka hui a Daopei Lu ma ASH. Ua mālama ʻia ka 65th Annual Meeting o ka American Society of Hematology (ASH) ma waho pūnaewele (San Diego, USA) a ma ka pūnaewele ma Dekemaba 9-12, 2023. Ua hōʻike nui kā mākou poʻe haumāna i kēia hui...
nānā i nā kikoʻī
ASH 2023|"Ka Leo o Lu Daopei" e hīmeni ana ma ke kahua honua

ASH 2023|"Ka Leo o Lu Daopei" e hīmeni ana ma ke kahua honua

2024-04-09
ʻO ka American Society of Hematology (ASH) ka hālāwai hoʻonaʻauao kiʻekiʻe loa ma ke kahua o ka hematology ma ka honua holoʻokoʻa. ʻO ka ʻoiaʻiʻo ua koho ʻia ka Halemai ʻo Lu Daopei ma ke ʻano he finalist no ka ASH no nā makahiki i hala iho nei e hōʻike piha ana i kāna mau hoʻokō hoʻonaʻauao ma ka f...
nānā i nā kikoʻī
Leo ASH o Kina | Polopeka Xian Zhang: Ka Pono Kiʻekiʻe a me ka Palekana o ka Nanobody Based Anti-BCMA CAR-T Therapy i ka mālama ʻana i nā maʻi me ka Relapsed a i ʻole Refractory Multiple Myeloma

Leo ASH o Kina | Polopeka Xian Zhang: Ka Pono Kiʻekiʻe a me ka Palekana o ka Nanobody Based Anti-BCMA CAR-T Therapy i ka mālama ʻana i nā maʻi me ka Relapsed a i ʻole Refractory Multiple Myeloma

2024-04-09
Ua mālama ʻia ka Hālāwai Makahiki 65 o ka ʻAhahui ʻAmelika o Hematology (ASH) mai ka lā 9 a i ka lā 12 o Dekemaba 2023, ma San Diego, USA. Ma ke ʻano he hanana hoʻonaʻauao hematology nui loa a piha loa o ka honua, ua huki ia i nā tausani o nā loea a me nā haumāna mai nā wahi a pau...
nānā i nā kikoʻī